MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The cortical thickness signature and future phenoconversion in isolated REM-sleep behavior disorder: a longitudinal analysis

    JH. Shin, JY. Lee, HJ. Kim, YK. Kim, EJ. Yoon, HW. Nam, B. Jeon (Seoul, Republic of Korea)

    Objective: To develop an imaging biomarker predicting subtype-specific phenoconversion in isolated REM sleep behavior disorder (iRBD), we aim at identifying MRI-driven cortical thickness signature in…
  • 2022 International Congress

    Critical appraisal of economic evaluation of biomarkers used for screening dementia

    M. Azharuddin, M. Sharma (New Delhi, India)

    Objective: The objective of this study was to assess the cost effectiveness of biomarkers used for early diagnosis of dementia disorders. Background: Dementia remains a…
  • 2022 International Congress

    Design of a prodromal screening study for subtypes in Parkinson’s Disease

    E. Schaeffer (Kiel, Germany)

    Objective: To follow-up prodromal Parkinson’s Disease (PD) subtypes in a longitudinal cohort study, validating new biomarkers and ethical guidelines for early detection of PD. Background:…
  • 2022 International Congress

    Assessment of mood symptoms and influence on disease in cervical dystonia

    S. Rafee, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: To compare mood symptom rating scales and influence of anxiety and depressive symptoms on motor severity and aspects of quality of life. Background: Cervical…
  • 2022 International Congress

    Deep brain stimulation of the subthalamic nucleus under general vs local anesthesia

    S. Asriyants, A. Tomskiy, A. Gamaleya, A. Poddubskaya, A. Sedov, I. Pronin (Moscow, Russian Federation)

    Objective: The aim of the study was to compare outcomes of the deep brain stimulation (DBS) of the subthalamic nucleus (STN) in patients with Parkinson’s…
  • 2022 International Congress

    Pseudo-INO in PSP? – A Case Report

    DK. Khandelwal, VM. Mathur (Jaipur, India)

    Objective: We herein describe a case of Progressive supranuclear palsy (PSP), who had diplopia as well as abduction nystagmus resembling an Internuclear ophthalmoplegia-like phenotype. Background: INO is mostly observed with…
  • 2022 International Congress

    Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative

    Z. Meyer, C. Marras, A. Naito, N. Dahodwala, A. Ramirez-Zamora, M. Rose Rafferty, M. Neault, J. Beck, R. Deleon, T. Davis, S. Mantri, K. Mills, J. Miyasaki, E. Nelson, A. Brown, D. Weintraub, A. Allen (Miami, USA)

    Objective: Assess the feasibility of systematic depression screening of people with Parkinson’s (PWP) and determine barriers in the specialist movement disorders setting. Background: While depression…
  • 2022 International Congress

    Neural activity during turning in Parkinson’s: influence of dual-task and freezing

    S. Stuart, R. Vitorio, J. Wagner, S. Makeig, M. Mancini (Whitley Bay, United Kingdom)

    Objective: To examine the neural activity during turning in Parkinson’s disease (PD). Background: Turning is impaired in PD with links to freezing of gait (FOG)…
  • 2022 International Congress

    Challenges in Outcome Measure Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease

    C. Gonzalez-Robles, M. Bartlett, M. Burnell, R. Chapman, R. Chaudhuri, C. Clarke, R. Ellis-Doyle, M. Hu, B. Huxford, A. Jha, M. Lawton, G. Mills, A. Noyce, P. Piccini, L. Rochester, J. Rudiger, C. Siu, D. van Wamelen, C. Williams-Gray, ML. Zeissler, H. Zetterberg, C. Carroll, T. Foltynie, R. Weil, A. Schrag (London, United Kingdom)

    Objective: The Edmond J Safra Accelerating Clinical Trials in Parkinson Disease (PD) initiative (EJS ACT-PD) aims to accelerate the identification of disease modifying treatment for…
  • 2022 International Congress

    Atypical parkinsonism presenting with isolated gaze palsy: implications for prognosis

    D. Damas, I. Carvalho, A. Jorge, I. Cunha, A. Morgadinho, J. Lemos, F. Moreira (Coimbra, Portugal)

    Objective: To present a case of atypical presentation of Progressive Supranuclear Palsy (PSP). Background: PSP is a clinical syndrome characterized by parkinsonism, supranuclear gaze palsy…
  • « Previous Page
  • 1
  • …
  • 669
  • 670
  • 671
  • 672
  • 673
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley